Literature DB >> 15714500

Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-oss), platelet-rich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings.

Kenji Ito1, Yoichi Yamada, Tetsuro Nagasaka, Shunsuke Baba, Minoru Ueda.   

Abstract

Recently, tissue engineering has become available as a regenerative treatment for bone defects. However, the evaluation of its success is limited to histological analysis, and its effects on mechanical hardness remain to be investigated. This study investigated mechanical strength in support of histological findings, specifically for tissue-engineered bone with mesenchymal stem cells (MSCs) and platelet-rich-plasma (PRP). Initially, teeth were extracted, and bone defects on both sides of the mandible were prepared with a trephine bar. The defects were implanted by using the following graft materials: 1) PRP, 2) PRP and dog MSCs (dMSCs), 3) autogenous bone (PCBM), 4) bone substitute (Bio-Oss), and 5) control (defects only). After 2, 4, 8, and 12 weeks of implantation, the defects were histologically assessed to examine their mechanical properties. According to histological observations, the dMSCs/PRP groups had well-formed mature bone compared with the control (defects only), Bio-Oss, and PRP groups. The Vickers hardness test values were 8 (control), 9 (PRP), not detected (Bio-Oss), 11 (PCBM), and 17 (dMSCs/PRP) after 2 weeks. Therefore, tissue-engineered bone can be used for early stage bone regeneration from the viewpoint of histology and mechanical properties. Copyright (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714500     DOI: 10.1002/jbm.a.30248

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  12 in total

1.  Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions.

Authors:  Mahesh H Mankani; Sergei A Kuznetsov; Grayson W Marshall; Pamela Gehron Robey
Journal:  Tissue Eng Part A       Date:  2008-12       Impact factor: 3.845

2.  Maxillary sinus floor augmentation on humans: Packing simulations and 8 months histomorphometric comparative study of anorganic bone matrix and β-tricalcium phosphate particles as grafting materials.

Authors:  A Martinez; J Franco; E Saiz; F Guitian
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2010-06-15       Impact factor: 7.328

3.  Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo.

Authors:  Guilhem Frescaline; Thibault Bouderlique; Leyya Mansoor; Gilles Carpentier; Brigitte Baroukh; Fernando Sineriz; Marina Trouillas; Jean-Louis Saffar; José Courty; Jean-Jacques Lataillade; Dulce Papy-Garcia; Patricia Albanese
Journal:  Tissue Eng Part A       Date:  2013-07       Impact factor: 3.845

Review 4.  Tissue-engineered mandibular bone reconstruction for continuity defects: a systematic approach to the literature.

Authors:  Nattharee Chanchareonsook; Rüdiger Junker; Leenaporn Jongpaiboonkit; John A Jansen
Journal:  Tissue Eng Part B Rev       Date:  2013-08-28       Impact factor: 6.389

5.  Research trends of platelet-rich plasma application in orthopaedics from 2002 to 2020: a bibliometric analysis.

Authors:  Bolin Ren; Xin Lv; Chao Tu; Zhihong Li
Journal:  Int Orthop       Date:  2021-08-02       Impact factor: 3.075

6.  Comparison between Platelet-Rich Plasma and Autologous Iliac Grafts for Tibial Osteotomy.

Authors:  Caio Oliveira D'Elia; Márcia Uchôa de Rezende; Alexandre Carneiro Bitar; Nelson Tatsui; José Ricardo Pécora; Arnaldo José Hernandez; Gilberto Luis Camanho
Journal:  Cartilage       Date:  2010-10       Impact factor: 4.634

Review 7.  Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.

Authors:  Mario Gimona; Karin Pachler; Sandra Laner-Plamberger; Katharina Schallmoser; Eva Rohde
Journal:  Int J Mol Sci       Date:  2017-06-03       Impact factor: 5.923

8.  Inhibition of PTGS1 promotes osteogenic differentiation of adipose-derived stem cells by suppressing NF-kB signaling.

Authors:  Yuejun Wang; Yunsong Liu; Min Zhang; Longwei Lv; Xiao Zhang; Ping Zhang; Yongsheng Zhou
Journal:  Stem Cell Res Ther       Date:  2019-02-13       Impact factor: 6.832

9.  Design of a Randomized Controlled Clinical Study of tissue-engineered osteogenic materials using bone marrow-derived mesenchymal cells for Maxillomandibular bone defects in Japan: the TEOM study protocol.

Authors:  Shinobu Shimizu; Shuhei Tsuchiya; Akihiro Hirakawa; Katsuyoshi Kato; Masahiko Ando; Masaaki Mizuno; Masashi Osugi; Kazuto Okabe; Wataru Katagiri; Hideharu Hibi
Journal:  BMC Oral Health       Date:  2019-04-30       Impact factor: 2.757

10.  The Number of Platelets in Patient's Blood Influences the Mechanical and Morphological Properties of PRP-Clot and Lysophosphatidic Acid Quantity in PRP.

Authors:  Michela Bosetti; Paolo Boffano; Alice Marchetti; Massimiliano Leigheb; Mattia Colli; Matteo Brucoli
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.